BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24076591)

  • 1. Arteether exerts antitumor activity and reduces CD4+CD25+FOXP3+ T-reg cells in vivo.
    Azimi Mohamadabadi M; Hassan ZM; Zavaran Hosseini A; Gholamzad M; Noori S; Mahdavi M; Maroof H
    Iran J Immunol; 2013 Sep; 10(3):139-49. PubMed ID: 24076591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of immunomodulatory effects of arteether administrated intratumorally.
    Azimi Mohamadabadi M; Hassan ZM; Zavaran Hosseini A; Noori S; Mahdavi M; Maroufizadeh S; Maroof H
    Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):57-62. PubMed ID: 23454779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo.
    Farsam V; Hassan ZM; Zavaran-Hosseini A; Noori S; Mahdavi M; Ranjbar M
    Int Immunopharmacol; 2011 Nov; 11(11):1802-8. PubMed ID: 21824530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model.
    Rahnama M; Mahmoudi M; Zamani Taghizadeh Rabe S; Balali-Mood M; Karimi G; Tabasi N; Riahi-Zanjani B
    J Immunotoxicol; 2015; 12(3):231-8. PubMed ID: 25027673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclareol reduces CD4+ CD25+ FoxP3+ Treg cells in a breast cancer model in vivo.
    Noori S; Hassan ZM; Salehian O
    Iran J Immunol; 2013 Mar; 10(1):10-21. PubMed ID: 23502334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone can improve the anti-tumor immunity by reducing the CD4+CD25+Foxp3+ regulatory T cells in BALB/c mice.
    Molla Hassan AT; Hassan ZM; Moazzeni SM; Mostafaie A; Shahabi S; Ebtekar M; Hashemi SM
    Int Immunopharmacol; 2009 Nov; 9(12):1381-6. PubMed ID: 19706340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long acting propranolol and HSP-70 rich tumor lysate reduce tumor growth and enhance immune response against fibrosarcoma in Balb/c mice.
    Khalili A; Hassan ZM; Shahabi S; Pourfathollah AA; Ostad SN; Noori S; Mahdavi M; Haybar H; Langroudi L
    Iran J Immunol; 2013 Jun; 10(2):70-82. PubMed ID: 23811546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-7 inhibits tumor growth by promoting T cell-mediated antitumor immunity in Meth A model.
    Tang JC; Shen GB; Wang SM; Wan YS; Wei YQ
    Immunol Lett; 2014; 158(1-2):159-66. PubMed ID: 24406503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoteichoic acid of Bifidobacterium in combination with 5-fluorouracil inhibit tumor growth and relieve the immunosuppression.
    Xie N; Wang Y; Wang Q; Li FR; Guo B
    Bull Cancer; 2012 May; 99(5):E55-63. PubMed ID: 22522606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tehranolide molecule modulates the immune response, reduce regulatory T cell and inhibits tumor growth in vivo.
    Noori S; Taghikhani M; Hassan ZM; Allameha A; Mostafaei A
    Mol Immunol; 2010 Apr; 47(7-8):1579-84. PubMed ID: 20138670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor and immunomodulatory effects of salvigenin on tumor bearing mice.
    Noori S; Hassan ZM; Yaghmaei B; Dolatkhah M
    Cell Immunol; 2013; 286(1-2):16-21. PubMed ID: 24270218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
    Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
    J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tehranolide could shift the immune response towards Th1 and modulate the intra-tumor infiltrated T regulatory cells.
    Noori S; Taghikhani M; Hassan ZM; Allameh A; Mostafaei A
    Iran J Immunol; 2009 Dec; 6(4):216-24. PubMed ID: 20054110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of excreted/secreted antigens of Toxoplasma gondii on CD4+ CD25+ Foxp3+ T cells and NK cells of melanoma-bearing mice].
    Jiao YM; Zhang L; Ge YY; Liang YJ; Yong W
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):301-6. PubMed ID: 22164498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor and immunomodulatory effects of Justicia spicigera Schltdl (Acanthaceae).
    Alonso-Castro AJ; Ortiz-Sánchez E; Domínguez F; Arana-Argáez V; Juárez-Vázquez Mdel C; Chávez M; Carranza-Álvarez C; Gaspar-Ramírez O; Espinosa-Reyes G; López-Toledo G; Ortiz-Andrade R; García-Carrancá A
    J Ethnopharmacol; 2012 Jun; 141(3):888-94. PubMed ID: 22465146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antitumoral effect of the American mistletoe Phoradendron serotinum (Raf.) M.C. Johnst. (Viscaceae) is associated with the release of immunity-related cytokines.
    Alonso-Castro AJ; Juárez-Vázquez Mdel C; Domínguez F; González-Sánchez I; Estrada-Castillón E; López-Toledo G; Chávez M; Cerbón MA; García-Carranca A
    J Ethnopharmacol; 2012 Aug; 142(3):857-64. PubMed ID: 22732726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclareol modulates the Treg intra-tumoral infiltrated cell and inhibits tumor growth in vivo.
    Noori S; Hassan ZM; Mohammadi M; Habibi Z; Sohrabi N; Bayanolhagh S
    Cell Immunol; 2010; 263(2):148-53. PubMed ID: 20409537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells.
    Yang Y; Paik JH; Cho D; Cho JA; Kim CW
    Int Immunopharmacol; 2008 Apr; 8(4):542-7. PubMed ID: 18328445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exposure to cigarette smoke alters later-life antitumor cytotoxic T-lymphocyte (CTL) activity via possible changes in T-regulatory cells.
    Ng SP; Silverstone AE; Lai ZW; Zelikoff JT
    J Toxicol Environ Health A; 2013; 76(19):1096-110. PubMed ID: 24274151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
    Salagianni M; Lekka E; Moustaki A; Iliopoulou EG; Baxevanis CN; Papamichail M; Perez SA
    J Immunol; 2011 Mar; 186(6):3327-35. PubMed ID: 21317394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.